I am deeply honored to receive the Public Engagement Award 2024 from the @BritPharmSoc presented by Prof. Sir Mark Caulfield. Thank you all for being an integral part of this achievement.
🌟 New Position Statement Alert 🌟
People with resistant hypertension (RH) face a higher risk of serious cardiovascular events. Our latest guidance outlines practical steps to investigate and manage RH effectively.
🔗 Read the full statement: https://t.co/KnIkU6aWqh
Good morning, Harrogate! 🌞
The BPS team has arrived in Harrogate, where we’re preparing for doors to open at #Pharmacology2024 tomorrow morning. We can’t wait to see you there!
I am pleased to announce that I have been elected as a fellow of the @BritPharmSoc
I am honoured to be elected this year and thank you to everyone who has supported me so far.
https://t.co/8OF70wzEas
We are thrilled to support Dr. Lip through our travel grant program and proud of her impactful contributions to cardiovascular research. Read more about her work: https://t.co/bBLNNDzm3h
@UofGlasgow@GlasgowBP@drstefanielip
@GordonB83559810@easyJet Tickets for onward travel should be compensated. Having no contingency planning for passengers is incredibly shocking. @easyJet
From GWAS to novel mechanism and clinical trial - hypertension precision medicine. New research funded by the British Heart Foundation, and published in the journal Hypertension. Here are the details in 10 tweets. #umod#hypertension#gwas#torasemide
https://t.co/XEfNbWMCfO
AHA Scientific Statements: Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
https://t.co/Qhn9fAoiLX
Hypertension & OH is complex
@spjuraschek fabulous overview
1. New definitions OH types
2. In some groups we should lower BP
3. Beware the drugs which are worst offenders
4. Start low, go slow, be judicious
#BGSconf